Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» palbociclib
palbociclib
3 Breast Cancer Drugs With Big Potential
Motley Fool
Thu, 04/10/14 - 10:37 am
breast cancer
Pfizer
Novartis
Eli Lilly
LEE011
LY2835219
palbociclib
CDK 4/6 inhibitors
Pfizer Breast Cancer Drug Helps Revive Discarded Strategy
Bloomberg
Mon, 04/7/14 - 08:46 am
Pfizer
Eli Lilly
palbociclib
Novartis
bemaciclib
breast cancer
CDK 4/6 inhibitors
Pfizer Breast Cancer Drug Results "As Impressive As I've Ever Seen," Researcher Says
Forbes
Sun, 04/6/14 - 11:07 am
Pfizer
palbociclib
breast cancer
Will Pfizer Unveil A Breast Cancer Blockbuster This Sunday?
Forbes
Thu, 04/3/14 - 06:14 pm
Pfizer
breast cancer
palbociclib
Pfizer Breast-Cancer Drug To Show If It's For Real
Investors.com
Mon, 03/10/14 - 07:51 pm
Pfizer
breast cancer
CDK 4/6 inhibitors
palbociclib
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks
Yahoo/24-7 Wall St
Mon, 03/10/14 - 10:13 am
Eli Lilly
Bristol-Myers Squibb
Merck
Pfizer
Yervoy
palbociclib
animal health
ramucirumab
Can Pfizer Crush the Market in 2014?
Motley Fool
Fri, 02/14/14 - 12:54 pm
Pfizer
palbociclib
breast cancer
vaccines
Prevnar
Will These Two Drugs Turn Around Losses at Pfizer?
Motley Fool
Sat, 02/8/14 - 10:33 am
Pfizer
palbociclib
breast cancer
vaccines
Prevnar vaccine
pneumonia
Here's Why Palbociclib is Helping Pfizer Avoid the Sell-Off
Motley Fool
Thu, 02/6/14 - 06:53 am
palbociclib
Pfizer
breast cancer
Pfizer Focuses on Experimental Drugs to Regain Revenue Losses
Wall St Cheat Sheet
Mon, 02/3/14 - 08:25 am
Pfizer
Prevnar
palbociclib
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Thu, 12/5/13 - 06:43 pm
Pfizer
GSK
melanoma
Bristol-Myers Squibb
AstraZeneca
Daiichi Sankyo
Novartis
Yervoy
palbociclib
Mekinist
Zelboraf
Pfizer Stock: 3 Things to Know Before 2014
Motley Fool
Mon, 12/2/13 - 08:34 am
Pfizer
RN-316
palbociclib
Xalkori
Pfizer Feels the Heat From Novartis
Wall St Cheat Sheet
Sat, 11/23/13 - 12:45 pm
Pfizer
Novartis
breast cancer
LEE011
palbociclib
Pfizer, Glaxo to initiate study of combination therapy in patients with melanoma
The Fly on the Wall
Thu, 11/21/13 - 08:25 am
GSK
Pfizer
melanoma
trametinib
palbociclib
Pfizer Vs. Novartis: A New Era In Breast Cancer Treatment
Seeking Alpha
Thu, 10/31/13 - 09:38 am
Pfizer
Novartis
breast cancer
palbociclib
LEE011
Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib
Fierce Biotech
Mon, 10/21/13 - 05:55 pm
Novartis
cyclin-dependent kinase inhibition [CDK]
Pfizer
palbociclib
LEE011
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
These 2 Health Care Stocks Could Win Big With FDA's New 'Breakthrough' Status
Yahoo/Street Authority
Fri, 06/14/13 - 12:21 pm
FDA
breakthrough therapies
LDK378
Novartis
palbociclib
Pfizer
lambrolizumab
Merck
Pfizer's New Breast Cancer Drug Could Be A Game Changer
Seeking Alpha
Mon, 04/15/13 - 08:40 am
Pfizer
breast cancer
palbociclib
AstraZeneca
Novartis
GSK
Bristol-Myers Squibb
Pfizer’s Big Breakthrough for Breast Cancer
Wall Street Cheat Street
Sun, 04/14/13 - 12:19 pm
Pfizer
palbociclib
breast cancer
Pages
« first
‹ previous
1
2
3
next ›
last »